Skip to main content
  • Login
Home

User menu

Mega menu

  • EASL.eu
  • Resources

    Resources

    • EASL Resources
      • All Resources
      • Basic Techniques in Experimental Hepatology at a Glance
      • Clinical Practice Guidelines
      • Congress Resources
      • COVID-19 Resources
      • EASL Molecular Tumour Boards
      • EASL Genetic Grand Round
      • EASL Policy Dialogues
      • EASL Quiz
      • ePosters
      • EASL DeepDive
      • EASL Journal Club
      • Nurses and AHPs
      • Online Courses
      • On-demand Webinars
      • Podcasts
      • Slide Decks
      • Webcasts
      • Webinars Calendar
    • EASL-Related Resources
      • EHC On-demand Webinar
      • ERN Rare-Liver On-demand Webinars
      • Baveno VII - Consensus Workshop
      • Baveno VII - Pediatric Research Workshop
    • Industry Resources
      • All Resources
      • Industry Symposia - EASL Monothematic Conference 2023
      • Industry Symposia - EASL Congress
      • Industry Symposia - EASL Liver Cancer Summit
      • Industry Symposia - EASL SLD Summit
      • GSK Resources
    • Patient Resources
      • All Resources
      • COVID-19 Resources
      • Documents
      • ePosters
      • Infographics
      • Patient Guidelines
      • Podcasts
      • Slide Decks
      • Takeaways
      • Webcasts
  • EASL Studio
  • EASL Campus Connect
    • My Community
    • Explore Community
      • EASL Community Feed
      • All Topics
      • Community FAQ's
    • Create
  • Our Sponsors
Keywords
Industry Topics
  • Show all (490)
  • Cirrhosis & Complications (37)
  • General Hepatology (83)
  • (-) Immune-Mediated and Cholestatic Diseases (98)
  • Liver Tumours (51)
  • Metabolism, Alcohol & Toxicity (141)
  • Public Health and Advocacy (1)
  • Viral Hepatitis (79)
Industry Resource Type
  • (-) Show all (98)
  • Infographics (1)
  • Webcasts (97)
Industry Congress resources
  • (-) Show all (90)
  • Digital ILC 2020 (1)
  • EASL Congress 2023 (26)
  • EASL Congress 2024 (28)
  • EASL Congress 2025 (12)
  • ILC 2021 (9)
  • ILC 2022 (14)
Industry Language
  • (-) Show all (44)
  • English (44)
Year
  • (-) Show all (98)
  • 2020 (1)
  • 2021 (9)
  • 2022 (14)
  • 2023 (26)
  • 2024 (36)
  • 2025 (12)
Company
  • (-) Show all (95)
  • Advanz Pharma (4)
  • Albireo Pharma (5)
  • Amgen (1)
  • BioMarin (1)
  • CymaBay (15)
  • Gilead Sciences (2)
  • GSK (28)
  • Intercept (10)
  • Ipsen (10)
  • Medscape (1)
  • Mirum Pharmaceuticals Inc (18)

Primary tabs

User menu
  • Resources 98 (current)
  • Session 78
Displaying 97 - 98 of 98
Immune-Mediated and Cholestatic Diseases
Q&A

Q&A

Webcasts
View
Immune-Mediated and Cholestatic Diseases
Course of Disease and Potential Novel Therapeutic Options in the Management of Patients With PFIC

Course of Disease and Potential Novel Therapeutic Options in the Management of Patients With PFIC

Webcasts
View

Pagination

  • First page « First
  • Previous page ‹ previous
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Current page 9
Displaying 97 - 98 of 98

Community Stream

Easl Community FeedMy Feed
Browse Stream
EASL.EU Home
Home of Hepatology
7 rue Daubin
1203 Geneva
Switzerland

Follow us:

Sign up to EASL News

©2019 - EASL. All Rights Reserved. Powered by Enovation.

Footer menu

  • Content Access policy
  • Privacy Policy
  • Cookie Policy